Meeting
2020 ASCO Virtual Scientific Program
Role of high-dose chemotherapy with autologous stem cell transplantation for primary central nervous system lymphoma: A systematic review.
Authors
Shaha Nabeel
Zucker School of Medicine/Northwell Health at Mather, Port Jefferson, NY
Shaha Nabeel , Zahoor Ahmed , Arafat Ali Farooqui , Zunairah Shah , Aqsa Ashraf , Hassan Imtiaz , Rabia Ashraf , Karun Neupane , Muhammad Salman Faisal , Faiz Anwer
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Central Nervous System Tumors
Track
Central Nervous System Tumors
Sub Track
Central Nervous System Tumors
Citation
J Clin Oncol 38: 2020 (suppl; abstr 2562)
DOI
10.1200/JCO.2020.38.15_suppl.2562
Abstract #
2562
Poster Bd #
53
Abstract Disclosures
Similar Posters
Poster
2012 ASCO Annual Meeting
CNS-directed chemotherapy including high-dose chemotherapy with autologous stem cell transplantation (HD-ASCT) for CNS relapse of aggressive lymphomas: Final analysis of a phase II study.
First Author: Agnieszka Korfel
Poster
2016 ASCO Annual Meeting
High-dose versus standard-dose rituximab with BEAM in autologous stem cell transplantation (SCT) for relapsed aggressive b-cell non-Hodgkin’s lymphomas (NHL).
First Author: Samer Ali Srour
Poster
2013 ASCO Annual Meeting
Preirradiation chemotherapy with methotrexate, rituximab, and temozolomide and post-irradiation temozolomide for primary central nervous system lymphoma: RTOG 0227 phase II study results.
First Author: Jon Glass
Poster
2013 ASCO Annual Meeting
Efficacy of radioimmunotherapy-based conditioning with high-dose chemotherapy and autologous stem cell transplantation for transformed lymphoma.
First Author: Amrita Y. Krishnan